Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A autosomal recessive cutis laxa type I that has material basis in homozygous or compound heterozygous mutation in the LTBP4 gene on chromosome 19q13
Features include always present findings: Hypertelorism, Joint hypermobility, Multiple bladder diverticula, and Long philtrum and others; and common findings: Pyloric stenosis, Low muscle tone (hypotonia), Large fontanelles, and Tracheomalacia and others. 47 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 5 | Bronchomalacia, Peripheral pulmonary artery stenosis, Pulmonary hypoplasia |
Digestive system | 4 | Gastroesophageal reflux, Ascites, Feeding difficulties |
Bones and joints | 2 | Joint hypermobility, Mild bone density loss (osteopenia) |
Muscles | 1 | Low muscle tone (hypotonia) |
Hormones | 1 | Adrenal hypoplasia |
Head and neck | 1 | Progeroid facial appearance |
Skin | 1 | Redundant skin |
Heart and blood vessels | 1 | Right ventricular hypertrophy |
Growth and development | 1 | Growth delay |
LTBP4-related cutis laxa is characterized by cutis laxa, early childhood-onset pulmonary emphysema, peripheral pulmonary artery stenosis, and other evidence of a generalized connective tissue disorder such as inguinal hernias and hollow visceral diverticula (e.g., intestine, bladder). LTBP4-related cutis laxa, a severe but variable disorder, has been reported to date in 25 individuals from 20 families [, , , , , ]. In most, cutis laxa was evident from birth. Pulmonary emphysema was present in nearly all. Table 2. LTBP4-Related Cutis Laxa: Frequency of Select Features Feature | Frequency
In nearly all | Common | Infrequent |
|---|---|---|
Pulmonary emphysema | Pulmonary infections | Pyloric stenosis |
Rectal prolapse | Gastrointestinal diverticula |
LTBP4 encodes latent transforming growth factor beta binding protein 4 (1,624 aa). Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space. Highest expression in Artery Aorta (752.6 TPM) and Nerve Tibial (709.9 TPM).
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies is associated with mutations in the LTBP4 gene on chromosome 19.
The LTBP4 protein participates in LTBP1, LTBP3 bind TGF-Beta pathway.
LTBP4 is classified as a druggable target (Druggable Genome category) with score 0.0.
No formal clinical diagnostic criteria have been established for LTBP4-related cutis laxa.
LTBP4-related cutis laxa should be suspected in individuals with the following clinical and family history findings.
Clinical findings
Loose redundant skin folds (cutis laxa)
Pulmonary emphysema
Gastrointestinal and/or urinary tract diverticula
Family history is consistent with autosomal recessive inheritance (e.g., affected sibs and/or parental consanguinity). Absence of a known family history does not preclude the diagnosis.
The diagnosis of LTBP4-related cutis laxa is established in a proband with cutis laxa and biallelic pathogenic (or likely pathogenic) variants in LTBP4 identified by molecular genetic testing . Note: (1) Per American College of Medical Ge...
Source: GeneReviews — "LTBP4-Related Cutis Laxa"
The primary clinical differential diagnoses to consider are autosomal recessive cutis laxa type 1A (ARCL1A), autosomal recessive cutis laxa type 1B (ARCL1B), and autosomal dominant cutis laxa type 1 (ADCL1): • ARCL1A (FBLN5-related cutis laxa) is characterized by cutis laxa, early childhood-onset pulmonary emphysema, peripheral pulmonary artery stenosis, and other evidence of a generalized connective tissue disorder such as inguinal hernias and hollow visceral diverticula (e.g., intestine, bladder). Occasionally, supravalvular aortic stenosis is observed. Considerable overlap exists between FBLN5- and LTBP4-related cutis laxa and the two entities are difficult to distinguish from each other purely on a clinical basis. In FBLN5-related cutis laxa, the skin features may be more pronounced. In LTBP-related cutis laxa, supravalvular aortic stenosis has not yet been observed, while bladder and gastrointestinal diverticula as well as rectal prolapse are more frequent. • ARCL1B (EFEMP2-related cutis laxa) is characterized by cutis laxa and systemic involvement, most commonly arterial tortuosity, aneurysms, and stenosis; retrognathia; joint laxity; and arachnodactyly. The severe arterial tortuosity seen in EFEMP2-related cutis laxa is absent in LTBP4-related cutis laxa. • ADCL1 (ELN-related cutis laxa) presents with generalized cutis laxa of variable severity. Aortic root dilatation and emphysema may occur as early as childhood and are progressive. However, emphysema is usually milder than in LTBP4-related cutis laxa . ARCL1A, ARCL1B, ADCL1 and other disorders to consider in the differential diagnosis of LTBP4-related cutis laxa are summarized in . Table 3. Disorders to Consider in the Differential Diagnosis of LTBP4-Related Cutis Laxa
Genetic testing for LTBP4 is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies. The disease remains an area of unmet medical need.
No clinical practice guidelines for LTBP4-related cutis laxa have been published. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with LTBP4-related cutis laxa, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 4. Recommended Evaluations Following Initial Diagnosis in Individuals with LTBP4-Related Cutis Laxa
System/Concern | Evaluation | Comment |
|---|---|---|
emphysema | Assessment of lung function | Incl oxygen saturation, spirometry, lung volumes diffusion capacity; Chest radiograph or high-resolution CT scan; Bronchoscopy if clinically indicated |
concerns | Eval by a pediatric gastroenterologist | Visualization of GI tract by gastrographin ingestion or enema may be needed.; Diaphragmatic hernia should be excluded. Genitourinary |
tract concerns | Complete ultrasound of urinary tract. | Incl detailed eval of bladder for bladder diverticula. A voiding cystoureterogram may be needed to complement bladder ultrasound. |
abnormality | Pediatric cardiology eval incl echocardiography | Other evals as directed by cardiologist Hypotonia/ |
Hyperlaxity |
Source: GeneReviews — "LTBP4-Related Cutis Laxa"
View trials for cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies
Table 6. Recommended Surveillance for Individuals with LTBP4-Related Cutis Laxa
System/Concern | Evaluation | Frequency |
|---|---|---|
emphysema | Oxygen saturation | Daily; can be monitored at home in younger children Pulmonary function oxygenation |
Gastrointestinal tract | Repeat imaging | Case by case as determined by specialist involved in care Genitourinary Cardiovascular |
Hypovitaminoses1 | 25-hydroxyvitamin D level | Annually 1. Due to avoidance of sunlight; see . |
Source: GeneReviews — "LTBP4-Related Cutis Laxa"
Phenotype severity distribution: 8 always present features, 14 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies.
3 publications have been identified in PubMed for cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies. Research spans Case Report / Case Series (100%).
Shoburu K (2025). [PMID: 40189904](https://pubmed.ncbi.nlm.nih.gov/40189904/). *Pediatr Int*. [Case Report / Case Series]
Teixeira J (2025). [PMID: 40194804](https://pubmed.ncbi.nlm.nih.gov/40194804/). *BMJ Case Rep*. [Case Report / Case Series]
Senapati D (2025). [PMID: 40709863](https://pubmed.ncbi.nlm.nih.gov/40709863/). *Indian Dermatol Online J*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 8:32 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Gastrointestinal elongation/tortuosity
Source: GeneReviews — "LTBP4-Related Cutis Laxa"
Disorder |
|---|
MOI |
|---|
Clinical Findings |
|---|
Comment |
|---|
Cutis laxa | Emphysema | Aneurysms | ID/DD | Bladderdiverticula |
ALDH18A1 | De Barsy syndrome A (ARCL3A) (See Neurocutaneous Disorders due to Mitochondrial Proline Synthesis Defects.) | AR | + | – |
ADCL3 (See Neurocutaneous Disorders due to Mitochondrial Proline Synthesis Defects.) | AD | + | – | – |
ATP6V1A | ARCL2D (OMIM 617403) | AR | ++ | – |
Source: GeneReviews — "LTBP4-Related Cutis Laxa"
Genetic |
counseling | By genetics professionals1 | To obtain a pedigree inform affected persons their families re nature, MOI, implications of LTBP4-related cutis laxa in order to facilitate medical personal decision making Family support resources |
Treatment of Manifestations in Individuals with LTBP4-Related Cutis Laxa Manifestation/Concern | Treatment | Considerations/Other Pulmonary emphysema |
concerns | Care by (pediatric) cardiologist w/experience in connective tissue pathology | Treatment of clinically relevant pulmonary artery stenosis |
Hyperlaxity | PT for muscle strength stability | PT = physical therapist/therapy; RSV = respiratory syncytial virus Surveillance Table 6. |